List of Elysium Therapeutics, Inc. patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11318132 Diversion-resistant opioid formulations	Patent 11318132 was granted and assigned to Elysium Therapeutics, Inc. on May, 2022 by the United States Patent and Trademark Office.	‌ Elysium Therapeutics, Inc.	‌ Elysium Therapeutics, Inc.	United States Patent and Trademark Office	11318132	May 3, 2022
‌ US Patent 10335406 Opioid compositions resistant to overdose and abuse	Patent 10335406 was granted and assigned to Elysium Therapeutics, Inc. on July, 2019 by the United States Patent and Trademark Office.	‌ Elysium Therapeutics, Inc.	‌ Elysium Therapeutics, Inc.	United States Patent and Trademark Office	10335406	July 2, 2019
‌ US Patent 10314839 Diversion-resistant opioid formulations	Patent 10314839 was granted and assigned to Elysium Therapeutics, Inc. on June, 2019 by the United States Patent and Trademark Office.	‌ Elysium Therapeutics, Inc.	‌ Elysium Therapeutics, Inc.	United States Patent and Trademark Office	10314839	June 11, 2019
‌ US Patent 9808452 Polysubunit opioid prodrugs resistant to overdose and abuse	Patent 9808452 was granted and assigned to Elysium Therapeutics, Inc. on November, 2017 by the United States Patent and Trademark Office.	‌ Elysium Therapeutics, Inc.	‌ Elysium Therapeutics, Inc.	United States Patent and Trademark Office	9808452	November 7, 2017
‌ US Patent 10251878 Polysubunit opioid prodrugs resistant to overdose and abuse	Patent 10251878 was granted and assigned to Elysium Therapeutics, Inc. on April, 2019 by the United States Patent and Trademark Office.	‌ Elysium Therapeutics, Inc.	‌ Elysium Therapeutics, Inc.	United States Patent and Trademark Office	10251878	April 9, 2019
‌ US Patent 11154549 Opioid compositions resistant to overdose and abuse	Patent 11154549 was granted and assigned to Elysium Therapeutics, Inc. on October, 2021 by the United States Patent and Trademark Office.	‌ Elysium Therapeutics, Inc.	‌ Elysium Therapeutics, Inc.	United States Patent and Trademark Office	11154549	October 26, 2021